The diversity

of LAB has been characterized in other type

The diversity

of LAB has been characterized in other types of fermentation processes. In the United States, the fermentation process uses corn starch or fiber hydrolysates as substrate for fermentation. In this process, L. acidophilus, L. agilis, L. amylovorus, L. brevis, L. casei, L. hilgardii, L. fermentum, L. plantarum and W. paramesenteroides are commonly found [6, 7]. The bacterial diversity was also analyzed in ethanol fermentation processes in Vietnam [12]. L. brevis, L. plantarum, Pediococcus pentosaceus, Weissella confusa and W. paramesenteroides were the most frequently found LAB. Moreover, acetic acid bacteria SBE-��-CD (Acetobacter orientalis and A. pasteurianus), amylase-producing bacteria (Bacillus subtilis, B. circulans, B. amyloliquefaciens and B. sporothermodurans) and some plant pathogen bacteria (Burkholderia ubonensis, Ralstonia solanacearum and Pelomonas puraquae) were also reported. The species Lactobacillus vini was observed in association with the growth of the yeast Dekkera bruxellensis in a Swedish bioethanol refinery [13]. This process passed by a period

of decrease in fermentation before stabilization. The present study also found a high abundance of Dekkera bruxellensis (107 CFUs/mL), possibly indicating an association between this yeast and LAB. Effects of LAB on Sacharomyces cerevisiae viability were reported by the inoculation of L. fermentum and L. delbrueckii Vitamin B12 in wheat mash batch fermentation [14]. Lactobacillus paracasei was reported to affect yeast viability when lactic acid concentration in the process exceeded 8 g/L [15]. This effect is more

pronounced when in combination with acetic acid [16]. Induction of yeast flocculation has been associated with some L. fermentum strains in synergy with the presence of calcium, which leads to loss of yeast viability [17]. Decrease of yeast cell viability was also induced by inactivated cells of L. fermentum, suggesting that bacterial metabolites can interfere in the yeast population [18]. Strains of L. plantarum, L. fructivorans, L. fructosus and L. buchneri were also able to induce yeast flocculation depending on the cell density [19, 20]. Experiments performed at laboratory scale simulating the contamination with L. fermentum showed that viability of the yeast cells, sugar consumption and ethanol yield were severely affected when acetic acid was higher than 4.8 g/L [10]. In the present work observations such as the microbiota alterations throughout the process, the presence of distinct populations of L. vini and L. fermentum, and the co-ocurrence of high numbers of D. bruxellensis and L. vini indicate a Defactinib complex microbial ecology in the bioethanol process.

33 11 33 ± 3 94 9 65 ± 2 98 Eyes Closed COM Excursion Area 32 85 

33 11.33 ± 3.94 9.65 ± 2.98 Eyes Closed COM Excursion Area 32.85 ± 13.6 33.87 ± 12.0 32.54 ± 11.1 28.28 ± 8.36 Elbow Extension Peak Torque @ 60°/sec (N · m)* 46.79 ± 14.2 51.64 ± 13.4 47.09 ± 14.4 60.04 ± 22.6 Elbow Extension Peak Torque @ 180°/sec (N · m)† 30.65 ± 11.7 32.48 ± 9.7 30.65 ± 8.5 34.55 ± 10.5 Elbow Extension see more Average Power @ 60°/sec (W)† 42.82 ± 15.0 46.58 ± 13.1 42.43 ± 13.2 54.68 ± 20.3 Elbow Extension Average Power @ 180°/sec (W)† 60.11 ± 28.3 63.58 ± 25.1 54.80 ± 22.0 68.03 ± 25.0 CH5424802 purchase Elbow Flexion Peak Torque @ 60°/sec (N · m)† 47.94 ± 11.7

54.98 ± 14.4 48.26 ± 15.6 58.05 ± 20.1 Elbow Flexion Peak Torque @ 180°/sec (N · m)† 32.99 ± 8.8 38.35 ± 11.6 32.90 ± 11.9 39.05 ± 13.08 Elbow Flexion Average Power @ 60°/sec (W)* 44.1 ± 11.0 51.05 ± 14.4 45.21 ± 16.1 56.40 ± 20.3 Elbow Flexion Average Power @ 180°/sec (W) 58.27 ± 19.7 68.42 ± 27.0 58.97 ± 31.0 70.09 ± 28.2 Knee Extension Peak Torque @ 60°/sec (N · m)Ω 122.5 ± 32.8 103.9 ± 25.6 124.99 ± 42.8 114.7 ± 44.6 Knee Extension Peak Torque @ 180°/sec (N · m) 83.7 ± 21.5 76.2 ± 15.9 85.24 ± 28.7 74.82 ± 29.5 Knee Extension

Average Power @ 60°/sec (W)Ω 101.5 ± 27.6 88.9 ± 21.5 106.4 ± 37.3 94.8 ± 25.5 Knee Extension Average Power @ 180°/sec (W) 157.6 ± 46.9 146.0 ± 30.3 173.3 ± 76.7 BIRB 796 clinical trial 139.7 ± 59.9 Knee Flexion Peak Torque @ 60°/sec (N · m) 64.4 ± 14.6 57.1 ± 12.9 71.0 ± 24.8 64.8 ± 24.9 Knee Flexion Peak Torque @ 180°/sec (N · m) 48.2 ± 14.2 45.4 ± 9.4 56.1 ± 21.6 46.9 ± 21.4 Knee Flexion Average Power @ 60°/sec (W) 56.4 ± 15.8 53.5 ± 14.6 66.5 ± 26.6 61.1 ± 24.8 Knee Flexion Average Power @ 180°/sec (W) 89.5 ± 36.7 84.2 ± 23.6 114.0 ± 54.1 92.5 ± 46.2 1-RM = 1 repetition maximum; SEBT = Star excursion balance test; COM = center of mass; kg = kilogram; cm = centimeter; sec = second; N.m = newton meter; W = watts. Ω = Significant Ureohydrolase decrement with training in StemSport condition only, p < 0.05. Vertical jump Vertical jump increased 7.2% with placebo (p = 0.03) and 10.6% with SS (p =0.001), but no significant between group differences (p > 0.05; Table 2).

Isokinetic strength Seven of the eight measures of isokinetic elbow flexion and extension strength improved in the placebo condition compared to only two measures in the SS condition (Table 2). No pre- to post-training improvements were observed for the measures of isokinetic knee extension and flexion strength. Post hoc tests revealed decrements in of two of the eight measures of isokinetic knee extension and flexion strength in the SS condition (Table 2).

1, Appendix 1) Plot size was roughly based on the extent of the

1, Appendix 1). Plot size was roughly based on the extent of the forest types within the park and

varied from 0.04 ha (one plot), 0.25 ha (two plots), to 1 ha (five plots). All trees with a diameter at breast height over 1 cm were marked and identified using scientific and local names and species codes for morphospecies by trained teams of local fieldworkers and expert botanists. Specimen (fertile when possible) were collected of all species and stored in a herbarium at the local Isabela State University. Morphospecies were used consistently in the entire study for species that could not be identified. see more Voucher specimens were identified

at the Philippine national herbarium, at the herbarium of the University of the Philippines’ Institute of Biology, and by visiting experts. Nearly all specimens could be selleck chemicals llc identified to genus level and 45% were identified to species level. Bird and bat species diversity was determined by Van Weerd from 1999 to 2006 in survey plots of varying size (Fig. 1, Appendix 1) using a variety of methods to obtain the most complete species lists possible. Only data gathered in the four selected forest types have been used here and data were pooled for each survey plot. In mangrove forest one survey plot for birds and bats was established; in lowland dipterocarp forest, data were gathered in 10 survey plots for bats and eight for birds; in ultrabasic forest five plots for bats and four for birds were used and in montane forest four plots for both birds and bats were used. Within a survey plot fixed transect and point count localities were established to record birds, using both visual and vocal identification. Counts were

conducted in the morning from 5.00 to 10.00 and late afternoon from 16.00 to 18.30. Transects were generally 0.5 km long, had no fixed belt width, and followed hunting or wildlife trails. Point counts (15–60 min depending on new species detections, no fixed belt) were spaced to avoid RAD001 double counting and placed Astemizole at stratified random positions along trails. Mist nets were used to detect skulking and nocturnal birds and to survey bats. Mist nets were placed along creeks, along edges of small forest gaps and within forest interior at various heights. Mist net length was between 100 and 200 m (10–20 nets) and netting duration between two and 9 days. Species accumulation curves were constructed in field to determine stopping times. Surveys always lasted more than three full days with a maximum of 10 days. Bird species were identified following Kennedy et al. (2000). Bats were identified using Ingle and Heaney (1992).

In sum, the result indicated that PLAG1 was a novel prognostic pr

In sum, the result indicated that PLAG1 was a novel prognostic predictor for HCC patients. Figure 4 The prognostic significance of KPNA2 and PLAG1 expression. Kaplan-Meier analyses of recurrence-free survival

(a) and overall survival (b) GDC-0994 chemical structure in HCC MI-503 ic50 patients stratified by KPNA2 expression status. Kaplan-Meier analyses of recurrence-free survival (c) and overall survival (d) in HCC patients stratified by PLAG1 expression status. The survival curves were compared using a Long-rank test. Table 3 The clinico-pathological characteristics of patients with positive KPNA2 expression when grouped by nuclear enrichment of PLAG1 Variate PLAG1 ▲ P-value Negative Positive All cases 53 99   Age (year), ≤60:>60 38:15 82:17 0.143 Gender, male:female 48:5 87:12 0.789 Child-Pugh, A:B 46:6 85:10 1.000 HBs antigen, positive:negative 47:6 86:13 0.803 HBe antigen positive:negative 7:46 22:77 0.201 AFP (ug/L), >20:≤20 20: 33 36: 63 0.862 Tumor size (cm), >5:≤5 30:23 67:32 0.005* No. tumor, Solitary:Multiple 44:9 81:19 0.607 Edmondson Grade, I + II:III + IV 3:50 8:91 0.748 Vascular invasion, Present:Absent 35:18 67:32 0.858 Micro-metastases, Present:Absent 41:12 72:27 0.566 ▲: PLAG1 status in tumoral tissues. *represents

statistical significance. The positive PLAG1 expression is the only predictor for survival of KPNA2-positive HCC Furthermore, we found that patients with positive KPNA2 and positive PLAG1expression (KpPp) in tumor have the poorest RFS and OS compared to other groups (Figure 5a-b), suggesting the combination of high KPNA2 and PLAG1 density in nucleus would add accuracy to predict the buy VRT752271 prognosis of HCC patients. It is noteworthy that Protirelin the differential prognosis between PLAG1-negative HCC patients with positive

or negative KPNA2 staining shows no significance (Figure 5a, RFS: KpPn vs KnPn, p = 0.226; Figure 5b, OS: KpPn vs KnPn, p = 0.438), confirming the clinical importance of PLAG1 for the role of KPNA2 in HCC. However, for patients with positive KPNA2 expression, the status of PLAG1 in nucleus could significantly associate with tumor size (Table 3) and predict the RFS and OS (Figure 5a, RFS: KpPn vs KpPp, p = 0.001; Figure 5b, OS: KpPn vs KpPp, p = 0.001). Furthermore, multivariate analysis was applied to determine that the positive PLAG1 expression was the risk factor for prognosis of HCC patients (Table 4) and the only risk factor for prognosis of HCC patients with positive KPNA2 expression (Table 5). Collectively, the results revealed that PLAG1 was essential for clinical significance of KPNA2 and would add accuracy to stratify HCC patients with poor prognosis. Figure 5 The prognostic significance of the interaction between KPNA2 and PLAG1. Kaplan-Meier analyses of recurrence free survival (a) and overall survival (b) of HCC patients divided into four subgroups described in Figure 3. The survival curves were compared using a Long-rank test. ★ represents statistical significance; NS represents no significance.

This work was funded in part by the ANR “RhizocAMP” (ANR-10-BLAN-

This work was funded in part by the ANR “RhizocAMP” (ANR-10-BLAN-1719) and the Pôle de Compétitivité “Agrimip Innovation Sud Ouest”. This work is part of the “Laboratoire d’Excellence” (LABEX) entitled TULIP (ANR-10-LABX-41). Electronic supplementary material Additional file 1: SpdA, a putative Class III phosphodiesterase. (A) Phylogenetic tree generated with [1]. The tree shows the phylogenetic check details relationship of the 15 IPR004843-containing proteins of S. meliloti with known phosphodiesterases from M. tuberculosis (Rv0805), H. influenzae (Icc) and E. coli

(CpdA and CpdB). (B) Table showing the distribution of the five class III PDE subdomains among the 15 IPR004843-containing proteins from S. meliloti. (PDF 386 KB) Additional file 2: Plasmids used this website in this study. (PDF 364 KB) Additional file 3: Molecules and conditions tested for expression of spdA ex planta. (PDF 429 KB) Additional file 4: Enzymatic characteristics of purified Selleck MDV3100 SpdA. (A)Lineweaver-Burk representation of SpdA kinetics of hydrolysis of 2′, 3′ cAMP. Purified SpdA was assayed as described in methods. (B)SpdA kinetic values. (PDF 237 KB) Additional file 5: SpdA does not require metal cofactor for 2′, 3′ cAMP hydrolysis. (A) Activity assayed in absence (CT) or presence of ions chelators. (B) SpdA activity in absence (CT) or presence of added bivalent ions.

(PDF 245 KB) Additional file 6: 2′, 3′ cAMP weakens smc02178-lacZ expression. (A) smc02178-lacZ expression was monitored ex planta in S.meliloti 1021 WT and ΔSpdA background strains after addition of 2.5 mM 3′, 5′-cAMP and/or 7.5 mM 2′, 3′-cAMP. ***p < 1.3E-06, **p < 0.0001, *p < 0.003 with respect to the wild type. (B) hemA-lacZ expression was monitored ex planta in S. meliloti 1021 WT and ΔSpdA background strains after addition of 2.5 mM 3′, 5′-cAMP and/or 7.5 mM 2′, 3′-cAMP. (PDF 547 KB) Additional file 7: Growth characteristics and stress adaptability of the ΔSpdA mutant. (A) Growth curves of 1021 WT and ΔSpdA mutant strains in LBMC or in VGM supplemented or not with 7.5 mM

2′, 3′ cAMP. (B and C) sensitivity of 1021 WT and ΔSpdA strains to SDS (B) and heat shock (C) (see methods for details). (PDF 274 KB) Additional file 8: spdA mutant symbiotic phenotype. (A) Nodulation kinetics on M. sativa following inoculation with S. meliloti 1021 and ΔSpdA mutant. (B) Dry weight of M. sativa shoots 35 dpi (C and D). Expression pattern of the smc02178-lacZ reporter gene fusion in young (7dpi) nodules of M. sativa following inoculation with S. meliloti 1021 (C) and ΔSpdA mutant (D). (PDF 513 KB) Additional file 9: Bacterial strains used in this study. (PDF 373 KB) Additional file 10: Primers and oligonucleotides used in this work. (PDF 326 KB) References 1. Jones KM, Kobayashi H, Davies BW, Taga ME, Walker GC: How rhizobial symbionts invade plants: the Sinorhizobium-Medicago model. Nat Rev Microbiol 2007,5(8):619–633.PubMedCentralPubMedCrossRef 2.

The experimental traces in general represent the averages of thre

The experimental traces in general represent the averages of three samples each illuminated once. The simulation

and fitting of the experimental polyphasic fluorescence induction curve with its algorithmic representation F FIA(t) was done with dedicated optimization routines. The fit parameters (rate constants, heterogeneity, fraction, etc.) of the simulation curve F FIA(t) were estimated after application of dedicated routines provided by appropriate software (Mathcad 13, MathSoft, Inc. Cambridge, MA, USA) which calculates the parameter values (vector) for which the least mean square function is minimal, where NN is the number of data points (in most experiments NN ≥50). Reduction of data points was in some cases purposely applied selleck chemical for F FIA(t) curves to facilitate better comparison with the experimental curve F exp(t). Analysis with fluorescence induction algorithm It has been shown (Vredenberg and Prásil 2009; Vredenberg 2011) that

the variable fluorescence during the OJ phase in the 0.01–1 ms time range is nearly exclusively, if not completely due to the release of primary photochemical quenching q PP and is represented by F PP(t) with $$ F^\textPP selleck chemicals (t) = 1 + nF_\textv \cdot q^\textdsq (t) \cdot [(1 - \beta ) \cdot \frack_\textL k_\textL + k_\textAB + \beta \cdot (1 + (1 - e^ - \phi k_\textL t ) \cdot e^ - k_2\textAB t )] $$ (1)in which nF v (=F m STF −F o)/F o) is the normalized variable fluorescence, \( q^\textdsq (t) = 1 – \texte^ – k_\textL t , \) β is the fraction of QB-nonreducing Methamphetamine RCs, Φ(0 ≤ Φ < 1)is an efficiency factor for energy trapping in semi-closed QB-nonreducing RCs, and k L, k AB, and k 2AB are the rate constants of light excitation and of oxidation of the single- and double-reduced primary quinone acceptor QA of PSII, respectively. Similarly it was shown that the variable fluorescence during the JI phase in the 1–30 ms time range is nearly exclusive due to the release of photoelectrochemical quenching q PE and is in approximation represented by F PE(t) with $$ F^\textPE (t) = 1 + nF_\textv \cdot

\ [1 - f^\textPPsc (t)] \cdot [1 - e^ - k_\textqbf \cdot t ] \cdot \frack_\textqbf k_\textqbf + k_\textHthyl + 1\ \cdot [1 - e^ - k_\textqbf \cdot t ] \cdot \frack_\textqbf k_\textqbf + k_\textHthyl $$ (2)in which f PPsc(t) is the fraction of semi-closed RCs containing QA − (see for definitions and equations Vredenberg 2011), k qbf is the rate constant attributed to that of the change in pH at the QA − QB redox side of PSII (related to the actual rate constant of proton pumping by the trans-thylakoid proton pump), and k Hthyl the actual passive trans-thylakoid proton leak (selleck screening library conductance). For the experiments presented in this article changes in k qbf and k Hthyl will be of prime importance to be considered.

Figure 1 Schematic diagram of the CdS/ZnO/Ti nanostructured solar

Figure 1 Schematic diagram of the CdS/ZnO/Ti nanostructured solar cell. The photovoltaic performance was characterized under an AM 1.5 G filter at 100 mW/cm2 using a Newport Oriel 94022A Solar Simulator (Model 94022A, Newport, OH, USA), as calibrated using a certified OSI standard silicon photodiode. A

sourcemeter (2400, Selleckchem NCT-501 Keithley Instruments Inc., Cleveland, OH, USA) was used for electrical characterization during the measurements. Results and discussion Morphology and crystal structure of the nanostructured photoanodes The employed weaved titanium wire is flexible and of a diameter of about 85 μm with quite smooth surface. The color of the weaved titanium wire changed from gray to white after the deposition of ZnO nanosheets. Figure 2a shows the typical FESEM images of ZnO nanosheet arrays grown on weaved titanium wires. The surface of the titanium cylinder wires is covered totally and uniformly with ZnO nanosheet arrays, which would provide a large area for the deposition of CdS nanoparticles. Figure 2b Trichostatin A shows the cross-sectional

SEM image of ZnO nanosheets. It is apparent that all products consist of a large number of well-aligned sheet-like nanostructures. The SEM image clearly indicates that the film is constructed by assembling nanosheets in a compact way and the nanosheets are vertically oriented to the surface of titanium wires with different angles to each other. The average film thickness is about 8 to 10 μm. Figure 2c,d shows the top view of the ZnO nanosheets and CdS/ZnO nanostructures at a high magnification, respectively. The space between nanosheets presents an

easily accessed open structure for the deposition of CdS nanoparticles, which is very important aminophylline for the performance of solar cells. Furthermore, this open structure could provide an easy filling of electrolyte into the space between the nanosheets and is beneficial to hole diffusion from CdS nanoparticles to counter electrode. By comparing Figure 2c,d, it can be clearly seen that the CdS nanoparticles were uniformly deposited onto ZnO nanosheets. The CdS nanoparticles make direct contact with the ZnO nanosheet surface, forming a firm connection on the ZnO nanosheets with a type II heterojunction, which may greatly enhance charge transport, charge separation, and overall photocurrent efficiency of the solar device. Figure 2 Typical FESEM images of ZnO nanosheets on weaved titanium wire substrate. (a) The low-magnification and (c) high-magnification FESEM images of ZnO nanosheets. (b) The cross-sectional view of ZnO nanosheets. (d) ZnO nanosheets deposited with CdS nanoparticles for 20 cycles. XRD patterns of ZnO/Ti and CdS/ZnO/Ti nanostructures are shown in Figure 3.

p 253–307 9 Nachman PH, Jennette C, Falk RJ Primary glomerula

p. 253–307. 9. Nachman PH, Jennette C, Falk RJ. Primary glomerular disease. In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu AL, Brenner BM, editors. Brenner & Rector’s The Kidney. 9th ed. Elsevier Saunders: Philadelphia; 2012. p. 1100–91. 10. Rennke HG. Secondary membranoproliferative glomerulonephritis. Kidney

Int. 1995;47(2):643–56.PubMedCrossRef 11. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33(6):355–74.PubMedCrossRef 12. Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M, Inuma H, Sasaki T, Kaizuka M, Tamura N, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol. 1995;6(2):220–3.PubMed NCT-501 13. Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, Nadasdy T, D’Agati VD. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009;20(9):2055–64.PubMedCrossRef 14. Sethi S, Nester CM, Smith RJ. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int. 2012;81(5):434–41.PubMedCrossRef 15. Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol. 2012;8(11):634–42.PubMedCrossRef”

Adrenomedullin (AM) is comprised of 52 amino acids and was originally isolated in pheochromocytoma tissue by its ability to elevate cAMP in rat platelets. It is now recognized as a potent circulating vasodilatory peptide which is secreted by ubiquitous cells and organs [1]. Because the cytoprotective effect of AM is mediated by the cAMP signaling pathway, it is expected that AM is involved in various cellular processes [2]. Circulating AM is mainly secreted from vascular endothelial and smooth muscle cells. AM is processed from its

precursor as the intermediate form. Subsequently, the intermediate form is converted by enzymatic amidation [3] to the biologically active next mature form of AM (mAM). Since AM is biologically active only after C-terminal amidation of immature AM, it is necessary to determine the level of mAM in order to investigate the pathological role of AM [4]. It has also been reported that hyperglycemia enhances AM expression in the vessels, indicating that AM is involved in the regulation of glycemic PF-01367338 molecular weight control [5]. Plasma AM concentration in diabetic patients is closely associated with diabetic vascular complications [6]. However, only limited information on mAM level or amidation activity is available. Generally, the dialysate used in peritoneal dialysis (PD) has a high glucose concentration of 1.5–2.5 %; this high glucose concentration leads to deterioration of the peritoneum.

Scripta Mater 2009, 60:240 10 1016/j scriptamat 2008 10 019Cross

Scripta Mater 2009, 60:240. 10.1016/j.scriptamat.2008.10.019CrossRef 21. Li W, Liu P, Zhao YS, Ma FC, Liu XK, Chen XH, He DH: Structure, mechanical properties and thermal stability of CrAlN/ZrO 2 nanomultilayers deposited by magnetron sputtering. J Alloys Compd 2013, 562:5–10.CrossRef 22. Li W, Liu P, Zhao YS, Zhang K, Ma FC, Liu XK, Chen XH, He DH: SiN x thickness dependent morphology and MI-503 solubility dmso mechanical properties of CrAlN/SiN x nanomultilayers. Thin Solid Films 2013, 534:367–372.CrossRef 23. Kato M, Mori T, Schwartz LH: Hardening by spinodal modulated structure.

Acta Metall 1980, 28:285–290. 10.1016/0001-6160(80)90163-7CrossRef 24. Mirkarimi PB, Barnett SA, Hubbard KM, Jervis TR, Hultman L: Structure and mechanical properties of epitaxial TiN/V 0.3 Nb 0.7  N(100) superlattices. J Mater Res 1994, 9:1456–1467. 10.1557/JMR.1994.1456CrossRef 25. Shinn M, Barnett SA: Effect of superlattice layer elastic moduli on hardness. Appl Phys Selleckchem Nutlin 3 Lett 1994, 64:61–63. 10.1063/1.110922CrossRef 26. Hsu TY, Chang HB: On calculation of M S and driving force for martensitic transformation in Fe-C. Acta Metall 1984, 32:343–348. 10.1016/0001-6160(84)90107-XCrossRef

27. Hsu TY: An approach for the calculation of M S in iron-base alloys. J Mater Sci 1985, 20:23–31. 10.1007/BF00555894CrossRef 28. Chang HB, Hsu TY: Thermodynamic prediction of M S and driving force for martensitic transformation in Fe-Mn-C alloys. Acta Metall 1986, 34:333–338. 10.1016/0001-6160(86)90204-XCrossRef 29. Hsu TY, Chang HB, Luo SF: On thermodynamic calculation of M S and on driving force for martensitic transformations in Fe-C. J Mater Sci 1983, 18:3206–3212. 10.1007/BF00544144CrossRef 30. Gautier E, Simon A, Collette G, Beck G: Effect of stress and strain on martensitic transformation in a MTMR9 Fe-Ni-Mo-C alloy with a high M S temperature. J de Phys 1982, 43:473–477. RG-7388 Competing interests The authors declare that they have no competing interests. Authors’ contributions WL designed the experiment and

wrote the article. PL, KZ, and FM carried out the synthesis of the monolithic FeNi film and FeNi/V nanomultilayered films. XL, XC, and DH assisted in the technical support for measurements (XRD and HRTEM) as well as the data analysis. All authors read and approved the final manuscript.”
“Background One of the important applications of nanomaterials metallic nanoparticles (NPs) is to manufacture fine-pitch electrical line patterns for organic transistors, radio frequency identification (RFID) antennas, or ultra-large-scale integration (ULSI) interconnections not only because of the high electrical conductivity and flexibility in handling, but also the low processing temperature [1, 2]. The reduced processing temperature is due to the large surface-to-volume ratio of the particles leading to a dramatic lowering of the melting point and sintering transition.

Antimicrob Agents Chemother 2003,47(2):665–669 PubMedCrossRef 24

Antimicrob Agents Chemother 2003,47(2):665–669.PubMedCrossRef 24. Ruzin A, Keeney D, Bradford PA: AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob Agents Chemother 2005,49(2):791–793.PubMedCrossRef 25. Ruzin A, Visalli MA, Keeney D, Bradford PA: Influence of transcriptional activator RamA on expression SB202190 purchase of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother 2005,49(3):1017–1022.PubMedCrossRef 26. Keeney D,

Ruzin A, Bradford PA: RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline buy AZD1152 in Enterobacter cloacae. Microbial drug resistance (Larchmont,

NY 2007,13(1):1–6.CrossRef 27. Keeney D, Ruzin A, McAleese F, Murphy E, Bradford PA: MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 2008,61(1):46–53.PubMedCrossRef 28. Hentschke M, Christner M, Sobottka I, Aepfelbacher M, Rohde H: Combined ramR mutation and presence of a Tn1721-associated tet(A) variant in a clinical isolate of Salmonella enterica serovar Hadar resistant to tigecycline. Antimicrob Agents Chemother 2010,54(3):1319–1322.PubMedCrossRef 29. Horiyama T, Nikaido E, Yamaguchi A, Nishino K: Roles of Salmonella multidrug efflux pumps in tigecycline resistance. J Antimicrob Chemother 2010,66(1):105–110.PubMedCrossRef 30. Vogel J: A rough guide to the non-coding RNA world of Salmonella. Mol Microbiol 2009,71(1):1–11.PubMedCrossRef 31. Brown DG, Swanson JK, Allen C: Two host-induced Ralstonia solanacearum genes, acrA and dinF, encode multidrug efflux pumps and contribute to bacterial wilt virulence. Appl Environ Microbiol 2007,73(9):2777–2786.PubMedCrossRef 32. Zhang XS, Garcia-Contreras R, Wood TK: YcfR (BhsA) influences Escherichia coli

biofilm CHIR98014 supplier formation through stress response and surface hydrophobicity. J Bacteriol 2007,189(8):3051–3062.PubMedCrossRef 33. Vanderpool CK, Gottesman S: The novel transcription factor SgrR coordinates the response to glucose-phosphate Atezolizumab stress. J Bacteriol 2007,189(6):2238–2248.PubMedCrossRef 34. Kroger C, Dillon SC, Cameron AD, Papenfort K, Sivasankaran SK, Hokamp K, Chao Y, Sittka A, Hebrard M, Handler K, et al.: The transcriptional landscape and small RNAs of Salmonella enterica serovar Typhimurium. Proc Natl Acad Sci U S A 2012,109((20):E1277-E1286.PubMedCrossRef 35. Waters LS, Storz G: Regulatory RNAs in bacteria. Cell 2009,136(4):615–628.PubMedCrossRef 36. Biedenbach DJ, Rhomberg PR, Mendes RE, Jones RN: Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102). Diagn Microbiol Infect Dis 2010,66(3):301–307.PubMedCrossRef 37.